Literature DB >> 6417718

Enhanced behavioral response to nicotine in an animal model of Alzheimer's disease.

C Ksir, D M Benson.   

Abstract

Three groups of rats received either kainic acid or vehicle in the ventral pallidum or no operation, and were then tested in photocell activity cages following recovery from surgery. Locomotor activity was measured following injections of saline, nicotine (0.1, 0.2, 0.4 mg/kg) or d-amphetamine (0.5, 1.0 mg/kg). The lesioned rats showed an enhanced locomotor response after injections of nicotine compared with sham operated or unoperated controls. In contrast, both lesioned and control rats showed increased activity after amphetamine; this effect was not influenced by the lesion. Since these lesions are known to produce neurochemical and cellular changes resembling those seen in human Alzheimer's disease, this increased response to nicotine might also be found in Alzheimer's patients and serve as the basis for a diagnostic test.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417718     DOI: 10.1007/BF00427277

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  9 in total

Review 1.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

2.  Decrease of neocortical choline acetyltransferase after lesion of the globus pallidus in the rat.

Authors:  P H Kelly; K E Moore
Journal:  Exp Neurol       Date:  1978-09-01       Impact factor: 5.330

3.  Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.

Authors:  P J Whitehouse; D L Price; A W Clark; J T Coyle; M R DeLong
Journal:  Ann Neurol       Date:  1981-08       Impact factor: 10.422

4.  The nucleus basalis magnocellularis: the origin of a cholinergic projection to the neocortex of the rat.

Authors:  J Lehmann; J I Nagy; S Atmadia; H C Fibiger
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

5.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

6.  Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo.

Authors:  R D Schwartz; K J Kellar
Journal:  Science       Date:  1983-04-08       Impact factor: 47.728

7.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

Authors:  P J Whitehouse; D L Price; R G Struble; A W Clark; J T Coyle; M R Delon
Journal:  Science       Date:  1982-03-05       Impact factor: 47.728

8.  Evidence for a cholinergic projection to neocortex from neurons in basal forebrain.

Authors:  M V Johnston; M McKinney; J T Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

9.  Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Authors:  E K Perry; B E Tomlinson; G Blessed; K Bergmann; P H Gibson; R H Perry
Journal:  Br Med J       Date:  1978-11-25
  9 in total
  6 in total

1.  Acute nicotinic blockade produces cognitive impairment in normal humans.

Authors:  P A Newhouse; A Potter; J Corwin; R Lenox
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Alterations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the rat nucleus basalis magnocellularis.

Authors:  I Miyai; S Ueno; S Yorifuji; H Fujimura; S Tarui
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

4.  Intravenous nicotine in Alzheimer's disease: a pilot study.

Authors:  P A Newhouse; T Sunderland; P N Tariot; C L Blumhardt; H Weingartner; A Mellow; D L Murphy
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 5.  Nicotine: abused substance and therapeutic agent.

Authors:  J Le Houezec
Journal:  J Psychiatry Neurosci       Date:  1998-03       Impact factor: 6.186

Review 6.  Modeling Alzheimer's disease with non-transgenic rat models.

Authors:  Laurent Lecanu; Vassilios Papadopoulos
Journal:  Alzheimers Res Ther       Date:  2013-05-01       Impact factor: 6.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.